Protease Signatures in Health and Disease: Toward Smart Diagnostic Platforms
- 1Polish Academy of Sciences , , ul. Ludwika Pasteura 3 , ,
- 2Polish Academy of Sciences , , Kasprzaka 44/52 , ,
Abstract
Proteases, a vast and functionally diverse class of enzymes, are fundamental regulators of many important biological processes. Their activity is tightly controlled in cells; aberrant protease activity is associated with numerous pathologies including cancer, infectious diseases, neurodegeneration, and metabolic disorders. Protease dysregulation is not necessarily a mere consequence of disease but often a critical driver of pathogenesis, making protease activity a powerful functional biomarker. Importantly, protease activity offers a dynamic readout of biological function, integrating upstream regulatory signals with local environmental conditions. This Perspective explores the field of protease-based diagnostics, charting its evolution from fundamental research to emerging clinical applications. We first establish the rationale for using proteases as functional biomarkers across a spectrum of diseases, with particular focus on oncology, infectious diseases, neurodegeneration, and diabetes mellitus. Current and emerging technologies for detecting protease activity are then critically evaluated, from traditional substrate-based assays to sophisticated mass spectrometry platforms and innovative biosensing strategies involving smart probes, nanotechnology, and synthetic biology; we distinguish approaches that are clinically established from those validated in human samples, demonstrated preclinically, or still at the proof-of-concept stage. We then discuss the translational potential and inherent challenges of the approaches. Finally, we examine how multiplexed, activity-based profiling could generate dynamic “protease signatures” that, when combined with appropriate statistical and artificial intelligence methods, may support early disease detection, longitudinal monitoring, patient stratification, and personalized therapeutic strategies. Despite significant challenges related to biological complexity, analytical specificity, and clinical translation, protease diagnostics have the potential to provide disease information that complements established biomarkers and imaging modalities and may contribute to precision medicine.
Related
- An acoustic-only multivariable diagnostic model for Parkinson's disease using bowel sound acoustic signatures
- Wearable sensor-derived gait signatures for Parkinson's disease: an exploratory diagnostic study integrating dimensionality reduction and machine learning.
- Diagnostic Yield and Clinical Phenotype in a Lithuanian Familial Hypercholesterolemia Cohort with Heterogeneous Sequencing Platforms
- Sex-related signatures in the plasma proteome not attributable to XX and XY chromosomes and their impact on health and disease
- Diagnostic antibodies at an inflection point: From discovery platforms to design‐oriented engineering
BibTeX
@article{janikiewicz2026protease,
title = {{Protease Signatures in Health and Disease: Toward Smart Diagnostic Platforms}},
author = {Justyna Janikiewicz and Aneta M. Dobosz and Lennart Brewitz and Agnieszka Dobrzyń and Marcin Drąg},
journal = {JACS Au},
year = {2026},
month = oct,
doi = {10.1021/jacsau.6c01272},
url = {https://pubs.acs.org/jaaucr/article/doi/10.1021/jacsau.6c01272/5453947/Protease-Signatures-in-Health-and-Disease-Toward},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Protease Signatures in Health and Disease: Toward Smart Diagnostic Platforms
AU - Justyna Janikiewicz
AU - Aneta M. Dobosz
AU - Lennart Brewitz
AU - Agnieszka Dobrzyń
AU - Marcin Drąg
PY - 2026
DA - 2026/10/19
JO - JACS Au
DO - 10.1021/jacsau.6c01272
UR - https://pubs.acs.org/jaaucr/article/doi/10.1021/jacsau.6c01272/5453947/Protease-Signatures-in-Health-and-Disease-Toward
AB - Proteases, a vast and functionally diverse class of enzymes, are fundamental regulators of many important biological processes. Their activity is tightly controlled in cells; aberrant protease activity is associated with numerous pathologies including cancer, infectious diseases, neurodegeneration, and metabolic disorders. Protease dysregulation is not necessarily a mere consequence of disease but often a critical driver of pathogenesis, making protease activity a powerful functional biomarker. Importantly, protease activity offers a dynamic readout of biological function, integrating upstream regulatory signals with local environmental conditions. This Perspective explores the field of protease-based diagnostics, charting its evolution from fundamental research to emerging clinical applications. We first establish the rationale for using proteases as functional biomarkers across a spectrum of diseases, with particular focus on oncology, infectious diseases, neurodegeneration, and diabetes mellitus. Current and emerging technologies for detecting protease activity are then critically evaluated, from traditional substrate-based assays to sophisticated mass spectrometry platforms and innovative biosensing strategies involving smart probes, nanotechnology, and synthetic biology; we distinguish approaches that are clinically established from those validated in human samples, demonstrated preclinically, or still at the proof-of-concept stage. We then discuss the translational potential and inherent challenges of the approaches. Finally, we examine how multiplexed, activity-based profiling could generate dynamic “protease signatures” that, when combined with appropriate statistical and artificial intelligence methods, may support early disease detection, longitudinal monitoring, patient stratification, and personalized therapeutic strategies. Despite significant challenges related to biological complexity, analytical specificity, and clinical translation, protease diagnostics have the potential to provide disease information that complements established biomarkers and imaging modalities and may contribute to precision medicine.
SN - 2691-3704
ER -